Article Sidebar

PDF
Date Published: 28/12/2022
Abstract Views: 268
Views PDF: 185
DOI: https://doi.org/10.51298/vmj.v520i1.3747
Issue
Vol. 520 No. 1A (2022)
Section
Các bài báo
How to Cite
Thị Thiết, Đào ., & Thị Kiều My, T. . (2022). CHARACTERISTICS OF vWF FUNCTION TESTS IN PATIENTS WITH VON WILLEBRAND DISEASE AT NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION. Vietnam Medical Journal, 520(1A). https://doi.org/10.51298/vmj.v520i1.3747

CHARACTERISTICS OF vWF FUNCTION TESTS IN PATIENTS WITH VON WILLEBRAND DISEASE AT NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION

Đào Thị Thiết1,, Trần Thị Kiều My1,2
1 National Institute of Hematology and Blood Transfusion
2 Hanoi Medical University

Main Article Content

Abstract

Objective: To evaluate functions of von Willebrand factor in patients with hereditary von Willebrand disease in NIHBT. Method: This prospective study included 40 patients with hereditary vWD in NIHBT. Results: Both Collagen-binding activity and von Willebrand activity determined with HaemosIL reduced in all patients and the levels were highest in type 1 and lowest in type 3. vWF CB/Ag and vWF Act/Ag ratio of vWD type 2 were significantly lower compared to type 1 (p<0,001). All patients with vWD type 2 had low ratio of Act/Ag, 20% of them had normal CB/Ag ratio. Activities determined with HaemosIL correlated with collagen-binding (r2 = 0,774, p < 0.0001)

Article Details

Keywords

von Willebrand disease, von Willebrand Activity, Collagen binding

References

1. Ng C, Motto DG, Di Paola J. Diagnostic approach to von Willebrand disease. Blood. 2015;125(13):2029-2037. doi:10.1182/blood-2014-08-528398
2. James PD, Connell NT, Ameer B, et al. ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv. 2021;5(1):280-300. doi:10.1182/bloodadvances.2020003265
3. Favaloro EJ, Pasalic L, Curnow J. Laboratory tests used to help diagnose von Willebrand disease: an update. Pathology (Phila). 2016;48(4):303-318. doi:10.1016/j.pathol.2016.03.001
4. Sucker C, Senft B, Scharf RE, Zotz RB. Determination of von Willebrand factor activity: evaluation of the HaemosIL assay in comparison with established procedures. Clin Appl Thromb Off J Int Acad Clin Appl Thromb. 2006;12(3):305-310. doi:10.1177/1076029606291428
5. Flood VH, Gill JC, Friedman KD, et al. Collagen binding provides a sensitive screen for variant von Willebrand disease. Clin Chem. 2013;59(4):684-691. doi:10.1373/clinchem.2012.199000
6. Federici AB. Current and emerging approaches for assessing von Willebrand disease in 2016. Int J Lab Hematol. 2016;38 Suppl 1:41-49. doi:10.1111/ijlh.12540
7. Favaloro EJ. Utility of the von Willebrand factor collagen binding assay in the diagnosis of von Willebrand disease. Am J Hematol. 2017;92(1):114-118. doi:10.1002/ajh.24556